Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pfizer Launches Embrex® Vaccine Manual Inovoject®

Published: Thursday, November 15, 2012
Last Updated: Thursday, November 15, 2012
Bookmark and Share
New, compact in ovo device for vaccine manufacturers.

Pfizer Animal Health Global Poultry has launched a new, compact in ovo device aimed at vaccine manufacturers and research institutes.

Embrex® Vaccine Manual Inovoject® (VMI) is the latest addition to the Embrex Vaccine Manufacturing Device (VMD) portfolio which already includes a range of in ovo devices used for the mass production of human influenza vaccines as well as other human and animal health egg-based vaccines.

This small, semi-automated device enables inoculation to be carried out in the laboratory setting, and so is aimed at vaccine manufacturers that require an alternative to high volume production. It could also be used for research and batch testing.

“The device is designed and produced specifically with the vaccine manufacturing environment in mind - for both human and animal health vaccines,” said Product Engineer, Joe Federowicz.

Federowicz continued, “It is only 30 inches wide, and thus can fit through ordinary laboratory doors. It is also fully enclosed so as to prevent dirt build up and other potential sources of contamination.”

According to Director, Gerardo Vera, Embrex VMI is likely to be of particular interest to vaccine manufacturers in Asia and Latin America markets.

“A typical animal health facility could probably install three to five of these machines, and each one would be used for a different vaccine,” Mr Vera said.

“The full-size Embrex Inovoject has been used by human vaccine manufacturers for many years for large scale flu vaccine production. The new Embrex VMI has the same industry-leading quality, features, functionality and reliability that customers have come to expect from the Embrex brand, which has been at the forefront of in ovo technology for 20 years,” said Mr Federowicz.

“We realized the need for an inoculation device which had the same engineering quality as other Embrex VMD products, but which could be installed in a much smaller area and was suited for smaller production runs.

“It took about a year to refine the design and bring it to market because the quality had to be superlative and up to industry standards. But I am really pleased with the result. The finish has to be seen to be believed: with no visible welds and mirror finish surfaces.”

Embrex VMI is available with the same world-class customer service and parts as offered with Pfizer Animal Health’s existing devices in the poultry business.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Faster, Cheaper Way to Produce New Antibiotics
A novel way of synthesising a promising new antibiotic has been identified by scientists at the University of Bristol.
Molecular Mechanism For Generating Specific Antibody Responses Discovered
Study could spur more ways to treat autoimmune disease, develop accurate vaccines.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Improving Flu Vaccine Effectiveness
NIH study finds factors that may influence influenza vaccine effectiveness.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!